Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms

The introduction of immunosuppressant belatacept, an inhibitor of the CD28-80/86 pathway, has improved 1-year outcomes in kidney transplant recipients with preexistent diabetes mellitus and has also reduced the risk of posttransplant diabetes mellitus. So far, no studies have compared a tacrolimus-b...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transplant Direct
Asıl Yazarlar: de Graav, Gretchen N., van der Zwan, Marieke, Baan, Carla C., Janssen, Joop A.M.J.L., Hesselink, Dennis A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2018
Konular:
Kidney Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5912016/
https://ncbi.nlm.nih.gov/pubmed/29707621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000767
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller